Abiopharma

Militello John 🟢 acquired 40.0K shares of ROCKET PHARMACEUTICALS, INC. (RCKT) Transaction Date: Sep 08, 2025 | Filing ID: 034431

BARRY JAMES 🟡 adjusted position in 3.7K shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $295.43 Transaction Date: Sep 05, 2025 | Filing ID: 000006

Director Allison Schwartz 🟡 adjusted position in 881 shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $295.43 Transaction Date: Sep 05, 2025 | Filing ID: 000006

DiVincenzo Jonathan P. 🟢 acquired 6.8K shares (1 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) Transaction Date: Sep 05, 2025 | Filing ID: 000004

UTHR: Notification

ENLOE COURTNEY C 🟡 adjusted position in 2.5K shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $295.43 Transaction Date: Sep 05, 2025 | Filing ID: 000005

Director SCHWARTZ NORMAN D 🟡 adjusted position in 14.9K shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $295.43 Transaction Date: Sep 05, 2025 | Filing ID: 000006

Landry Benjamin 🔴 sold 6.2K shares of Health Catalyst, Inc. (HCAT) at $3.35 Transaction Date: Sep 05, 2025 | Filing ID: 006142

Johnson & Johnson - U.S. FDA approval of INLEXZO™(gemcitabine intravesical system) set to transform how certain bladder cancers are treated

Mehta Rajat 🟢 acquired 7.3K shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) Transaction Date: Sep 05, 2025 | Filing ID: 000008

Director Malady Kyle 🔴 sold 667 shares of DEXCOM INC (DXCM) at $80.86 Transaction Date: Sep 05, 2025 | Filing ID: 000253

U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated

New Form 144 - Precipio, Inc. Filed: 2025-09-09 AccNo: 0001950047-25-006880 Size: 4 KB

New Form 144 - Certara, Inc. Filed: 2025-09-09 AccNo: 0001959173-25-005870 Size: 4 KB

Cousin Laetitia 🟡 adjusted position in 797 shares (2 derivative) of INSULET CORP (PODD) at $348.81 Transaction Date: Sep 08, 2025 | Filing ID: 000051